Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript
Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2024 Results Conference Call September 24, 2024 8:30 AM ET Company Participants Thomas Meyer -...
Therapeutics
Summit Therapeutics, Intel Stir Monday’s Afternoon Market Cap Stock Movers By Investing.com
Monday's market has seen notable movements across various stocks, with significant activity in both the mega-cap and large-cap categories. Investors...
Cargo therapeutics CEO sells over $250k in company stock By Investing.com
Cargo Therapeutics, Inc. (NASDAQ:CRGX) President and CEO Gina Chapman has recently engaged in significant stock transactions, according to the latest...
Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Michal Krakowiak/E+ via Getty Images Topline Summary and Update When I last wrote about Summit Therapeutics (NASDAQ:SMMT) back around the...
Structure Therapeutics: Overlooked Player In GLP-1 Weight Loss Field, Pay Attention (GPCR)
Hiroshi Watanabe/DigitalVision via Getty ImagesInvestment Overview - The GLP-1 Revolution - Structure Therapeutics Enters The Fray Glucagon-like peptide-1, or "GLP-1",...
Analyzing Tectonic Therapeutic’s Post-Merger Valuation And Prospects (NASDAQ:TECX)
Shutter2U Tectonic Therapeutic, Inc. (NASDAQ:TECX) is a pioneering biotechnology company dedicated to discovering and developing therapeutic biologics targeting G-protein-coupled receptors...
Why Verve Therapeutics Deserves A Spot On Your Watchlist (NASDAQ:VERV)
asbeVerve Therapeutics, Inc. (NASDAQ:VERV) is a biotechnology company based in Cambridge, Massachusetts, focusing on gene editing technology to develop one-dose...
Vivos Therapeutics reports mixed Q1 results, aims for growth By Investing.com
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million...
